Aspirin for primary prevention of atherosclerotic cardiovascular disease: advances in diagnosis and treatment

S Mora, JAE Manson - JAMA internal medicine, 2016 - jamanetwork.com
Importance Clinical decision making regarding the appropriate use of aspirin for the primary
prevention of atherosclerotic cardiovascular disease (ASCVD) events is complex, and …

Low-dose aspirin in the primary prevention of cardiovascular disease: shared decision making in clinical practice

S Mora, JM Ames, JAE Manson - Jama, 2016 - jamanetwork.com
Clinical decision makingregarding the appropriate use of aspirin for the primary prevention
of atherosclerotic cardiovascular disease (ASCVD) events is a complex process that …

Aspirin for primary prevention—time to rethink our approach

JS Berger - JAMA network open, 2022 - jamanetwork.com
Over the past decades, the medical community has witnessed a significant improvement in
cardiovascular disease (CVD) outcomes. Nonetheless, CVD remains a leading cause of …

Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US preventive services task force

JM Guirguis-Blake, CV Evans, LA Perdue, SI Bean… - Jama, 2022 - jamanetwork.com
Importance Low-dose aspirin is used for primary cardiovascular disease prevention and
may have benefits for colorectal cancer prevention. Objective To review the benefits and …

[HTML][HTML] Aspirin use to prevent cardiovascular disease and colorectal cancer: an evidence update for the US preventive services task force

JM Guirguis-Blake, CV Evans, LA Perdue, SI Bean… - 2022 - europepmc.org
Background Cardiovascular disease (CVD) is the leading cause of death and colorectal
cancer (CRC) is the third leading cause of death in the United States. Purpose To …

[HTML][HTML] Aspirin use to prevent cardiovascular disease and colorectal cancer: A decision analysis: Technical report

SP Dehmer, MV Maciosek, TJ Flottemesch - 2015 - europepmc.org
Background Evidence indicates that aspirin is effective for the primary prevention of
cardiovascular disease (CVD) and colorectal cancer (CRC), but regular use also increases …

Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the US Preventive Services Task Force

J Chubak, EP Whitlock, SB Williams… - Annals of internal …, 2016 - acpjournals.org
Background: Cancer is the second leading cause of death in the United States. Purpose: To
conduct systematic reviews of aspirin and 1) total cancer mortality and incidence in persons …

Rationale and design of the aspirin dosing—a patient-centric trial assessing benefits and long-term effectiveness (ADAPTABLE) trial

G Marquis-Gravel, MT Roe, HR Robertson… - JAMA …, 2020 - jamanetwork.com
Importance Determining the right dosage of aspirin for the secondary prevention treatment of
atherosclerotic cardiovascular disease (ASCVD) remains an unanswered and critical …

Aspirin for the primary prevention of cardiovascular disease and colorectal cancer: a decision analysis for the US Preventive Services Task Force

SP Dehmer, MV Maciosek, TJ Flottemesch… - Annals of internal …, 2016 - acpjournals.org
Background: Evidence indicates that aspirin is effective for the primary prevention of
cardiovascular disease (CVD) and colorectal cancer (CRC) but also increases the risk for …

[HTML][HTML] Aspirin use to prevent cardiovascular disease and colorectal cancer: an updated decision analysis for the US Preventive Services Task Force

SP Dehmer, LR O'Keefe, ES Grossman, MV Maciosek - 2022 - europepmc.org
Background Evidence indicates that aspirin is effective for preventing the first incidence (ie,
primary prevention) of cardiovascular disease (CVD) but regular use also increases risk for …